Scopus Asset Management’s Xylem XYL Stock Holding History

Scopus Asset Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.78M	Sell	40,000 -10,000	-20%	-$1.31M	0.08%	236
2025 Q4	$6.81M	Sell	50,000 -30,000	-38%	-$4.31M	0.11%	206
2025 Q3	$11.8M	Buy	80,000 +30,800	+63%	+$4.27M	0.16%	183
2025 Q2	$6.36M	Sell	49,200 -800	-2%	-$96.9K	0.11%	197
2025 Q1	$5.97M	Sell	50,000 -20,000	-29%	-$2.48M	0.12%	176
2024 Q4	$8.12M	Hold	70,000	–	–	0.19%	134
2024 Q3	$9.45M	Sell	70,000 -30,000	-30%	-$4.01M	0.17%	167
2024 Q2	$13.6M	Buy	+100,000	New	+$13.6M	0.27%	117
2017 Q3	–	Sell	-200,000	Closed	-$11.1M	–	363
2017 Q2	$11.1M	Buy	+200,000	New	+$10.4M	0.12%	166

Other funds holding XYL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Scopus Asset Management's XYL Position: Q1 2026 in Review

Scopus Asset Management reduced its Xylem (XYL) stake by 6.3% in Q1 2026, selling an estimated $1.31M and leaving 148,245 shares worth $17.7M. The position accounts for 0.31% of the portfolio, ranked #113.

Scopus Asset Management first reported a position in XYL in Q4 2015 and has held it in 19 quarters since. The position peaked at $30.1M in Q4 2017. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

Scopus Asset Management held 148,245 shares of Xylem worth $17.7M as of Q1 2026.
Scopus Asset Management sold 10,026 Xylem shares in Q1 2026, an estimated $1.31M.
Xylem made up 0.31% of Scopus Asset Management's portfolio in Q1 2026, its #113 holding.
Scopus Asset Management first reported a position in Xylem in Q4 2015 and has held it in 19 quarters since.
Scopus Asset Management's Xylem position peaked at $30.1M in Q4 2017.
1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Scopus Asset Management's 13F filing for Q1 2026, filed 15 May 2026.